产品封面图

162-21.2

收藏
  • 询价
  • 2026年07月09日
    avatar
    15金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 库存

      大量

    • 物种来源

      小鼠

    • 是否是肿瘤细胞

      0

    • 免疫类型

      IgG2a

    • 细胞形态

      淋巴样

    • 运输方式

      冻存运输

    • ATCC Number

      HB-241™

    • 生长状态

      悬浮生长

    Designations: 162-21.2
    Depositors:  LA Herzenberg
    Isotype: IgG2a
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension
    Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
    Morphology: lymphoblast

    Source: Cell Type: hybridoma: B lymphocyte;
    Cellular Products: immunoglobulin; monoclonal antibody; against Trop-1 antigen
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Comments: Animals were immunized with the human choriocarcinoma cell line BeWo.
    Spleen cells were fused with NS-1 myeloma cells.
    The antibody reacts with an antigen (Trop-1) present on trophoblast cells and on human choriocarcinomas.
    The antigen has also been detected on 4 of 4 human choriocarcinoma cell lines tested, on a fibrosarcoma cell line (HT1080C), on an erythroleukemia cell line (K562) and on the majority of human malignant epithelial cells and fetal epithelial precursors.
    The gene encoding the trop-1 antigen has been cloned.
    No staining was detected on peripheral blood cells.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Subculturing: Medium Renewal: Every 2 to 3 days
    Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
    References: 1309: Lipinski M, et al. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 78: 5147-5150, 1981. PubMed: 7029529
    22152: Strnad J, et al. Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA. Cancer Res. 49: 314-317, 1989. PubMed: 2463074
    22157: Klein CE, et al. Expression of 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs. J. Invest. Dermatol. 95: 74-82, 1990. PubMed: 2366004

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • Crystallization of Kinesin Family Motor Proteins

      .67 Åc=74.13 Å1.9 ÅMolecular replacement rK379PDB: 3KINP212121a=72.2 Åb=91.9 Åc=141.7 Å3.0 ÅMultiple isomorphous replacement Kar3 382-729PDB: 3KARP21a=44.1 Åb=81.2 Åc=48.3 Åß=105.8°2.3 ÅMolecular replacement and phases of three heavy atom derivatives

    • XBB.1.5 毒株的传播力为何这么强?北大曹云龙团队最新研究揭示相关机制

      。这一结果对指导疫苗研发等具有重要意义。 图片来源:bioRxiv 主要研究内容 在本研究中,该团队使用基于水疱性口炎病毒 (Vesicular Stomatitis Virus, VSV) 的假病毒进行中和试验,评估了在 BA.1、BA.5 或 BF.7 突破性感染 (BTI) 之前接受过 3 剂 CoronaVac 疫苗的康复人群血浆对 XBB.1.5 的中和滴度。其中一组 BA.5 BTI 患者接受了至少两剂量的 BNT162b2 或 mRNA-1273 也纳入了分析。 研究结果表明

    • F值表(方差齐性检验用)

      P=0.05 (双侧) r r(较大均方的自由度) n 2 2 3 4 5 6 7 8 9 10 12 15 20 30 60 00 1 799 364 899 922 937 948 957 963 969 977 985 993 1001 1010 1018 1 2 39.0 39.2 39.2 39.3 39.3 39.3 39.4 39.4 39.4 39.4 39.4 39.4 39.5 39.5 39.5 2 3 10.0 15.4 15

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥500
    北京百奥创新科技有限公司
    2025年07月10日询价
    询价
    ATCC细胞库
    2026年05月29日询价
    询价
    北京中源合聚生物科技有限公司
    2026年05月29日询价
    ¥1400
    上海盖宁生物科技有限公司
    2026年07月06日询价
    162-21.2
    询价